File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Anti-tumor efficacy of a recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma

TitleAnti-tumor efficacy of a recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma
Authors
Chow, APang, RChu, ANg, LPoon, R
KeywordsMedical sciences
Oncology
Issue Date2011
PublisherAmerican Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/
Citation
The 102nd Annual Meeting of the American Association for Cancer Research (AACR 2011), Orlando, FL., 2-6 April 2011. In Cancer Research, 2011, v. 71 n. 8 suppl. 1, abstract no. 5382 How to Cite?
DOI: http://dx.doi.org/10.1158/1538-7445.AM2011-5382
AbstractINTRODUCTION: Systemic chemotherapy of hepatocellular carcinoma (HCC) relies on few drugs and the response rates are low especially in patients with advanced HCC. HCC is considered as auxotrophic for arginine due to the lack of expression of argininosuccinate synthetase (ASS). Several recombinant human arginases were found to be effective in inhibiting liver, pancreatic and leukemic cell proliferation. Recently ...
DescriptionThis journal suppl. is conference proceedings of AACR 2011
Poster Presentations - Enhancing Efficacy of Targeted Agents: abstract no. 5382
Persistent Identifierhttp://hdl.handle.net/10722/137925
ISSN
0008-5472
2023 Impact Factor: 12.5
2023 SCImago Journal Rankings: 3.468
ISI Accession Number ID
WOS:000209701400482

 

DC FieldValueLanguage
dc.contributor.authorChow, Aen_US
dc.contributor.authorPang, Ren_US
dc.contributor.authorChu, Aen_US
dc.contributor.authorNg, Len_US
dc.contributor.authorPoon, Ren_US
dc.date.accessioned2011-08-26T14:36:59Z-
dc.date.available2011-08-26T14:36:59Z-
dc.date.issued2011en_US
dc.identifier.citationThe 102nd Annual Meeting of the American Association for Cancer Research (AACR 2011), Orlando, FL., 2-6 April 2011. In Cancer Research, 2011, v. 71 n. 8 suppl. 1, abstract no. 5382en_US
dc.identifier.issn0008-5472-
dc.identifier.urihttp://hdl.handle.net/10722/137925-
dc.descriptionThis journal suppl. is conference proceedings of AACR 2011-
dc.descriptionPoster Presentations - Enhancing Efficacy of Targeted Agents: abstract no. 5382-
dc.description.abstractINTRODUCTION: Systemic chemotherapy of hepatocellular carcinoma (HCC) relies on few drugs and the response rates are low especially in patients with advanced HCC. HCC is considered as auxotrophic for arginine due to the lack of expression of argininosuccinate synthetase (ASS). Several recombinant human arginases were found to be effective in inhibiting liver, pancreatic and leukemic cell proliferation. Recently ...-
dc.languageengen_US
dc.publisherAmerican Association for Cancer Research. The Journal's web site is located at http://cancerres.aacrjournals.org/-
dc.relation.ispartofCancer Researchen_US
dc.subjectMedical sciences-
dc.subjectOncology-
dc.titleAnti-tumor efficacy of a recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinomaen_US
dc.typeConference_Paperen_US
dc.identifier.emailChow, A: chowakm@hku.hken_US
dc.identifier.emailPang, R: robertap@hku.hken_US
dc.identifier.emailChu, A: bcccy@hku.hken_US
dc.identifier.emailPoon, R: poontp@hku.hken_US
dc.identifier.authorityPang, R=rp00274en_US
dc.identifier.authorityChu, A=rp00505en_US
dc.identifier.authorityPoon, R=rp00446en_US
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1158/1538-7445.AM2011-5382-
dc.identifier.hkuros191920en_US
dc.identifier.volume71-
dc.identifier.issue8 suppl. 1-
dc.identifier.isiWOS:000209701400482-
dc.publisher.placeUnited States-
dc.description.otherThe 102nd Annual Meeting of the American Association for Cancer Research (AACR 2011), Orlando, FL., 2-6 April 2011. In Cancer Research, 2011, v. 71 n. 8, suppl. 1, abstract no. 5382-
dc.identifier.issnl0008-5472-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats